Arcturus announces approval of a clinical trial application to advance arct-154, a next generation starr™ mrna vaccine targeting the sars-cov-2 delta variant and other variants of concern

San diego--(business wire)---- $arct #clinicaltrial--approval of a cta to advance arct-154, a next generation starr™ mrna vaccine targeting the sars-cov-2 delta variant and other variants of concern
ARCT Ratings Summary
ARCT Quant Ranking